Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on OTC Markets
Here is a table of 6 OTC cannabis stocks that are developing cannabis compound medicines.
6 Cannabis Pharma Stocks - OTC Markets | ||
---|---|---|
Name | Symbol | Recent Prices |
Axim Biotechnologies | AXIM | |
Cannabics Pharmaceuticals | CNBX | |
GB Sciences | GBLX | |
OWC Pharmaceutical Research | OWCP | |
PharmaCyte Biotech | PMCB | |
Vitality Biopharma | VBIO | |
Price charts from Alpha Vantage as of most recent close. |
Portfolio Values
To inspect the performance of the Cannabis Pharma Stocks - OTC Markets portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 5 stocks included in the portfolio computations are: AXIM, CNBX, GBLX, PMCB and VBIO. The current value of the portfolio assumes that $2,000.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. OWCP was excluded from the portfolio computations because of insufficient price data.The current value of the $10,000 investment is $516. The percent return is -94.84%. The annualized return is -44.73%.
5 Cannabis Pharma Stocks - OTC Markets Returns | ||
---|---|---|
Name | Symbol | % Return & Details |
Axim Biotechnologies | AXIM | -99.33% |
Cannabics Pharmaceuticals | CNBX | -97.83% |
GB Sciences | GBLX | -91.77% |
PharmaCyte Biotech | PMCB | -98.19% |
Vitality Biopharma | VBIO | -87.10% |
Portfolio Value Chart for Last 100 Daily Closes